EXMceuticals Inc. — Capital/Financing Update 2022

Apr 5, 2022

==> picture [82 x 33] intentionally omitted <==

EXMceuticals Announces Sale of Portugal Subsidiary

VANCOUVER, British Columbia, April 4, 2022 – EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “ Company ” or “ EXM ”) announces further to its news release of January 10, 2022, that it has sold EXMceuticals Portugal Lda, its Portuguese subsidiary, to an arm’s length purchaser for cash consideration of €80,000. The Company is seeking alternative business opportunities.

ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.

Jonathan Summers, Chairman

For further information contact: Investor Relations Email: julie@exmceuticals.com Tel : 1-403-554-1562

FOR MORE UPDATES ON THE COMPANY Follow us on Twitter: https://twitter.com/EXMceuticals Follow us on LinkedIn: https://www.linkedin.com/company/exmceuticalsinc/

Neither the CSE nor the FSE has approved nor disapproved the contents of this news release. Neither the CSE nor the FSE accepts responsibility for the adequacy or accuracy of this release.